Assignee profile:

Rigshospitalet

City:

Copenhagen Ø

Country:

Denmark

Published Applications:

12

Last publication date:

2026-01-08

Patent Grants:

4

Last grant date:

2025-02-18

Top Inventors for applications by Rigshospitalet

These are the the leading inventors for applications assigned to Rigshospitalet:

Recent patent applications by Rigshospitalet

Rigshospitalet based in Copenhagen Ø, DK has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2026-01-08
US20260007702A1
Human necessities

STEM CELL THERAPY BASED ON ADIPOSE-DERIVED STEM CELLS

#2 | 2025-10-02
US20250304939A1
Chemistry; metallurgy

TAILORED ANTI-FUNGAL DRUGS AND TOOLS TO DIAGNOSE INVASIVE FUNGAL INFECTIONS

#3 | 2025-06-05
US20250176944A1
Human necessities

A THREE DIMENSIONAL ULTRASOUND IMAGING DEVICE, RELATED SYSTEM, REFERENCE ELEMENT, AND METHOD

#4 | 2023-01-26
US20230022032A1
Human necessities

uPAR-TARGETED PHOTOTHERMAL OPTICAL PROBES FOR PHOTOTHERMAL THERAPY

#5 | 2022-08-11 ✅ Patent 12,226,495 granted on 2025-02-18
US20220249709A1
Human necessities

F-labeled novel tetrazines imaging probes for pretargeting in PET imaging

#6 | 2022-04-21
US20220119359A1
Chemistry; metallurgy

NOVEL TETRAZINE COMPOUNDS FOR IN VIVO IMAGING

#7 | 2018-11-15 ✅ Patent 12,433,916 granted on 2025-10-07
US20180325957A1
Human necessities

STEM CELL THERAPY BASED ON ADIPOSE-DERIVED STEM CELLS

#8 | 2017-11-23 ✅ Patent 11,203,622 granted on 2021-12-21
US20170334961A1
Chemistry; metallurgy

MASP isoforms as inhibitors of complement activation

#9 | 2014-09-18
US20140272998A1
Chemistry; metallurgy

DIAGNOSTIC MICRORNA PROFILING IN CUTANEOUS T-CELL LYMPHOMA (CTCL)

#10 | 2012-11-08
US20120282285A1
Chemistry; metallurgy

MASP ISOFORMS AS INHIBITORS OF COMPLEMENT ACTIVATION

#11 | 2012-04-26 ✅ Patent 9,012,154 granted on 2015-04-21
US20120101004A1
Physics

Ficolin-3 assay

#12 | 2011-03-24
US20110070601A1
Physics

CLASSIFICATION OF INDIVIDUALS SUFFERING FROM CARDIOVASCULAR DISEASES ACCORDING TO SURVIVAL PROGNOSES AS FOUND BY MEASURING THE LEVELS OF BIOMARKER YKL-40

Also check out Rigshospitalet's (Copenhagen Ø, Denmark) applicant profile with 9 patent applications submitted.

AssigneeID:

129282